CD1 PSA definition

CD1 PSA shall have the meaning assigned to such term in the recitals.
Sample 1Sample 2Sample 3

Examples of CD1 PSA in a sentence

  • The Lead Servicer, each Non-Lead Master Servicer and any Trustee will be entitled to interest on any Advance made in the manner and from the sources provided in the Note A-1-A PSA, the Note A-1-B1 PSA, the Note A-1-B2 PSA, the CD1 PSA, the Note A-2-B PSA or the Note A-3 PSA, as applicable.

  • The Lead Servicer, each Non-Lead Master Servicer and any Trustee will be entitled to interest on any Advance made in the manner and from the sources provided in the Note A-1-A PSA, the Note A-1-B PSA, the CD1 PSA, the Note A-2-B PSA or the Note A-3 PSA, as applicable.

Related to CD1 PSA

  • Note A-1 PSA means the pooling and servicing agreement or other comparable agreement entered into in connection with the Note A-1 Securitization.

  • Note A-2 PSA means the “pooling and servicing agreement” entered into in connection with the Note A-2 Securitization.

  • Note A-3 PSA means the “pooling and servicing agreement” entered into in connection with the Note A-3 Securitization.

  • Model PSA means that certain pooling and servicing agreement, dated as of July 1, 2023, relating to the BBCMS Mortgage Trust 2023-C20 securitization.

  • Note A-4 PSA means the “pooling and servicing agreement” entered into in connection with the Note A-4 Securitization.

  • Note A-6 PSA means the “pooling and servicing agreement” entered into in connection with the Note A-6 Securitization.

  • Lead Securitization PSA means (a) during the period from and after the Note A-2 Securitization Date and prior to the Note A-1 Securitization Date, the Note A-2 PSA and (b) from and after the Note A-1 Securitization Date, the Note A-1 PSA.

  • Note A-5 PSA means the “pooling and servicing agreement” entered into in connection with the Note A-5 Securitization.

  • CME Term SOFR Administrator means CME Group Benchmark Administration Limited as administrator of the forward-looking term Secured Overnight Financing Rate (SOFR) (or a successor administrator).

  • Term SOFR Administrator means CME Group Benchmark Administration Limited (CBA) (or a successor administrator of the Term SOFR Reference Rate selected by the Administrative Agent in its reasonable discretion).

  • Governance Term Sheet means the Governance Term Sheet attached as Exhibit F to the Restructuring Support Agreement.

  • Lead Depositor means the Depositor under the Lead Securitization Servicing Agreement.

  • Lead Securitization Directing Certificateholder means the “Directing Certificateholder” as defined in the Lead Securitization Servicing Agreement.

  • Phase IV Clinical Trial means a post-registrational Clinical Trial conducted in any country or countries and required as a condition to, or for the maintenance of, any Regulatory Approval for a Product in the Territory.

  • Phase IIb Clinical Trial means a clinical trial of a Product on sufficient numbers of patients that is designed to provide a preliminary determination of safety and efficacy of such Product in the target patient population over a range of doses and dose regimens.

  • Project labor agreement means an agreement by which labor organizations agree to terms and conditions of employment, to cooperate in resolving labor disputes, and to maintain labor peace on the Project.

  • Phase 1 Clinical Trial means a Clinical Trial of a Product on sufficient numbers of normal volunteers and/or patients that is designed to establish that such Product is safe for its intended use and to support its continued testing in Phase 2 Clinical Trials. For purposes of this Agreement, ‘initiation’ of a Phase 1 Clinical Trial for a Product means the first dosing of such Product in a human subject in a Phase 1 Clinical Trial.

  • Lead Securitization Controlling Class Representative means the “Controlling Class Representative” as defined in the Lead Securitization Servicing Agreement.

  • Non-Lead Depositor means the “depositor” under any Non-Lead Securitization Servicing Agreement.

  • Summary Subcontract Report (SSR) Coordinator, as used in this clause, means the individual at the department or agency level who is registered in eSRS and is responsible for acknowledging or rejecting SSRs in eSRS for the department or agency.

  • Clinical Trials means a controlled study in humans of the safety or efficacy of a Product, and includes, without limitation, such clinical trials as are designed to support expanded labeling or to satisfy the requirements of an Agency in connection with any Product Approval and any other human study used in research and Development of a Product.

  • Phase 2 Clinical Trial means a human clinical trial of a product in any country that would satisfy the requirements of 21 C.F.R. 312.21(b) and is intended to explore a variety of doses, dose response, and duration of effect, and to generate initial evidence of clinical safety and activity in a target patient population, or a similar clinical study prescribed by the relevant Regulatory Authorities in a country other than the United States.